ALT Altimmune Inc

Altimmune Inc is a clinical stage immunotherapeutic biotechnology company. It has two vaccine delivery platforms, RespirVec and Densigen.

$16.16  +0.60 (3.86%)
As of 06/23/2021 15:59:57 EST     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Small cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  10/06/2005
Outstanding shares:  38,396,843
Average volume:  2,230,293
Market cap:   $600,526,625
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    02155H200
ISIN:        US02155H2004
Sedol:      BFY7DC4
Valuation   (See tab for details)
PE ratio:   -9.95
PB ratio:   2.41
PS ratio:   0.00
Return on equity:   0.00%
Net income %:   0.00%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy